Inspire Medical Systems, INC Form 4 insider transactions

Shelley G. Broader, a director at Inspire Medical Systems, acquired 77 shares of common stock in lieu of cash fees on October 14, 2024.

Director Shawn McCormick sold 800 shares of Inspire Medical Systems (INSP) common stock at $220 per share on September 9, 2024, under a pre-arranged 10b5-1 trading plan.

John Rondoni, Chief Technology Officer of Inspire Medical Systems, sold 31 shares of common stock at a price of $215 per share on September 9, 2024, according to a Form 4 filing.

Chief Technology Officer of Inspire Medical Systems, John Rondoni, exercised stock options and sold shares under a pre-arranged Rule 10b5-1 trading plan.

Chief Commercial Officer Randy Ban of Inspire Medical Systems reports exercising stock options and selling shares under a pre-arranged 10b5-1 trading plan.

Director Shawn McCormick reports exercising stock options and disposing of shares of Inspire Medical Systems.

Melissa Mann, Chief People Officer at Inspire Medical Systems, received restricted stock units and an employee stock option on July 31, 2024.

Director Casey M. Tansey acquired 103 shares of Inspire Medical Systems, Inc. common stock at $138.58 per share in lieu of cash fees.

Georgia Melenikiotou, a director of Inspire Medical Systems, acquired 32 shares of common stock on July 15, 2024, in lieu of cash fees.

Director Gary Ellis acquired 154 shares of Inspire Medical Systems common stock on July 15, 2024, in lieu of cash fees.

Shelley G. Broader, a director at Inspire Medical Systems, acquired 117 shares of common stock on July 15, 2024, in lieu of cash fees, according to a Form 4 filing with the SEC.

CEO Timothy Herbert reported a gift of 3,000 common stock shares and updated his beneficial ownership in Inspire Medical Systems.

Charisse Y. Sparks, Chief Medical Officer of Inspire Medical Systems, reports receiving 64 shares of common stock as a gift on May 29, 2024, leaving her with a total of 3,628 shares.

Shawn McCormick, a director at Inspire Medical Systems, exercised stock options and acquired shares on May 10, 2024.

Cynthia Burks, a director of Inspire Medical Systems, received 716 shares of common stock as Restricted Stock Units (RSUs) and disposed of 1,385 shares on May 2, 2024.

Director Casey M. Tansey acquired 716 shares of Inspire Medical Systems, Inc. through restricted stock units and holds indirect ownership through family trusts.

Director Gary Ellis received 716 Restricted Stock Units (RSUs) from Inspire Medical Systems on May 2, 2024.

Dana G. Mead Jr., a director at Inspire Medical Systems, reported the acquisition of 716 Restricted Stock Units (RSUs) on May 2, 2024.

Myriam Curet, a director at Inspire Medical Systems, reported the acquisition of 716 shares of common stock through a restricted stock unit (RSU) award on May 2, 2024.

Director Georgia Melenikiotou acquired 716 Restricted Stock Units (RSUs) of Inspire Medical Systems, Inc. on May 2, 2024.

Director Shelley G. Broader reports acquiring 716 Restricted Stock Units (RSUs) of Inspire Medical Systems, Inc. on May 2, 2024.

Director Shawn McCormick reports acquisition of restricted stock units and disposal of common stock held in trust.

Director Marilyn Nelson exercised stock options and sold shares of Inspire Medical Systems on April 29, 2024.

Richard Buchholz, CFO of Inspire Medical Systems, reported the sale of 15,000 shares of common stock on April 17, 2024, according to a Form 4 filing with the SEC.

Gary Lee Ellis, a director at Inspire Medical Systems, acquired 70 shares of common stock on April 12, 2024, in lieu of cash fees.

Director Casey M. Tansey acquired 62 shares of Inspire Medical Systems, Inc. common stock in lieu of cash fees at a price of $231.74 per share.

Shelley G. Broader, a director at Inspire Medical Systems, acquired 70 shares of common stock on April 12, 2024, in lieu of cash fees.

Georgia Melenikiotou, a director at Inspire Medical Systems, acquired 56 shares of common stock on April 12, 2024, in lieu of cash fees.

Marilyn C. Nelson, a director at Inspire Medical Systems, acquired 107 shares of common stock in lieu of cash fees on April 12, 2024.

Timothy Herbert, CEO and President of Inspire Medical Systems, filed an amended SEC Form 4/A detailing multiple sales of common stock held indirectly through trusts and an LLC, executed on April 1, 2024, under a pre-arranged 10b5-1 trading plan.